• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米金刚石的最新协同作用:在用于治疗神经疾病的脑靶向药物传递中的作用。

Recent Synergy of Nanodiamonds: Role in Brain-Targeted Drug Delivery for the Management of Neurological Disorders.

机构信息

Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research-Raebareli, New Transit Campus, Bijnor-Sisendi Road, Sarojini Nagar, Near CRPF Base Camp, Lucknow, Uttar Pradesh, 226002, India.

出版信息

Mol Neurobiol. 2022 Aug;59(8):4806-4824. doi: 10.1007/s12035-022-02882-8. Epub 2022 May 27.

DOI:10.1007/s12035-022-02882-8
PMID:35618981
Abstract

The aim of the present review article is to summarize the role of nanodiamonds in various neurological diseases. We have taken related literature of making this review article from ScienceDirect, springer, Research gate, PubMed, Sci-finder, etc. The current approaches for treating neurological conditions such as glioblastoma includes chemotherapy or combination anti-retro viral therapy for HIV (human immunodeficiency virus) or use of anti-Alzheimer drugs during cognitive impairment. These approaches can provide only symptomatic relief as they do not target the cause of the disease due to their inability to penetrate the blood brain barrier. On long-term use, they may cause CNS toxicity due to accumulation in the brain. So nanodiamonds could prove as a promising approach in the brain targeting of the bioactive and to treat many neurological disorders such as Alzheimer's disease, Parkinson's disease, brain tumor (glioblastoma), HIV, amyotrophic multiple sclerosis, Huntington disease, stroke (cerebrovascular attack), batten disease, schizophrenia, epilepsy, and bacterial infections (encephalitis, sepsis, and meningitis) due to their ability to penetrate the blood-brain barrier and owing to their excellent surface properties, i.e., nano size and high surface area, ease of functionalization, multiple drug binding, and biocompatibility; they can be useful for brain targeted drug delivery with minimal side effects.

摘要

本文旨在总结纳米金刚石在各种神经疾病中的作用。我们从 ScienceDirect、springer、Research gate、PubMed、Sci-finder 等相关文献中获取了撰写本文的资料。目前治疗神经疾病的方法包括化疗或联合抗逆转录病毒疗法治疗 HIV(人类免疫缺陷病毒),或在认知障碍期间使用抗阿尔茨海默病药物。这些方法只能提供症状缓解,因为由于它们无法穿透血脑屏障,因此无法针对疾病的原因。长期使用,由于在大脑中积累,它们可能会引起中枢神经系统毒性。因此,纳米金刚石由于其穿透血脑屏障的能力以及能够治疗多种神经疾病,如阿尔茨海默病、帕金森病、脑瘤(胶质母细胞瘤)、HIV、肌萎缩性多发性硬化症、亨廷顿病、中风(脑血管攻击)、巴滕病、精神分裂症、癫痫和细菌性感染(脑炎、败血症和脑膜炎),因此可能成为生物活性物质的脑靶向治疗的一种有前途的方法。由于其具有穿透血脑屏障的能力,以及出色的表面特性,即纳米尺寸和高表面积、易于功能化、可结合多种药物和生物相容性,它们可用于脑靶向药物递送,副作用最小。

相似文献

1
Recent Synergy of Nanodiamonds: Role in Brain-Targeted Drug Delivery for the Management of Neurological Disorders.纳米金刚石的最新协同作用:在用于治疗神经疾病的脑靶向药物传递中的作用。
Mol Neurobiol. 2022 Aug;59(8):4806-4824. doi: 10.1007/s12035-022-02882-8. Epub 2022 May 27.
2
Drug targeting strategies into the brain for treating neurological diseases.针对治疗神经疾病的脑部药物靶向策略。
J Neurosci Methods. 2019 Jan 1;311:133-146. doi: 10.1016/j.jneumeth.2018.10.015. Epub 2018 Oct 16.
3
Recent Advancements in Nanodiamond Mediated Brain Targeted Drug Delivery and Bioimaging of Brain Ailments: A Holistic Review.纳米金刚石介导的脑靶向药物递送及脑部疾病生物成像的最新进展:全面综述
Pharm Nanotechnol. 2022;10(1):42-55. doi: 10.2174/2211738510666211222111938.
4
Growing synergy of nanodiamonds in neurodegenerative interventions.纳米金刚石在神经退行性疾病干预中的协同生长。
Drug Discov Today. 2019 Feb;24(2):584-594. doi: 10.1016/j.drudis.2018.10.012. Epub 2018 Nov 5.
5
Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders.鼻腔给药的纳米制剂:治疗神经障碍的一种有潜力的方法。
Molecules. 2020 Apr 21;25(8):1929. doi: 10.3390/molecules25081929.
6
Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.神经疾病中的谷氨酸受体抗体:抗AMPA - GluR3抗体、抗NMDA - NR1抗体、抗NMDA - NR2A/B抗体、抗mGluR1抗体或抗mGluR5抗体存在于以下疾病患者的亚组中:癫痫、脑炎、小脑共济失调、系统性红斑狼疮(SLE)和神经精神性SLE、干燥综合征、精神分裂症、躁狂症或中风。这些自身免疫性抗谷氨酸受体抗体可在少数脑区与神经元结合,激活谷氨酸受体,降低谷氨酸受体的表达,损害谷氨酸诱导的信号传导和功能,激活血脑屏障内皮细胞,杀死神经元,损伤大脑,在动物模型中诱发行为/精神/认知异常和共济失调,并且在一些患者中可通过免疫疗法去除或使其失活。
J Neural Transm (Vienna). 2014 Aug;121(8):1029-75. doi: 10.1007/s00702-014-1193-3. Epub 2014 Aug 1.
7
Mechanistic Insights, Treatment Paradigms, and Clinical Progress in Neurological Disorders: Current and Future Prospects.神经疾病的机制见解、治疗模式和临床进展:现状与未来展望。
Int J Mol Sci. 2023 Jan 10;24(2):1340. doi: 10.3390/ijms24021340.
8
Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting.近期在纳米脂质载体的制备及其脑靶向应用方面的策略和进展。
J Control Release. 2020 May 10;321:372-415. doi: 10.1016/j.jconrel.2020.02.020. Epub 2020 Feb 12.
9
Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.纳米载体的进步使药物能够穿透血脑屏障靶向递送到大脑。
Int J Pharm. 2019 Mar 25;559:360-372. doi: 10.1016/j.ijpharm.2019.01.056. Epub 2019 Feb 2.
10
Nanoparticles in the treatment and diagnosis of neurological disorders: untamed dragon with fire power to heal.神经紊乱治疗与诊断中的纳米粒子:驯服携带火力的龙以治愈疾病。
Nanomedicine. 2012 May;8(4):399-414. doi: 10.1016/j.nano.2011.08.006. Epub 2011 Sep 1.

引用本文的文献

1
Nanodiamonds in biomedical research: Therapeutic applications and beyond.生物医学研究中的纳米金刚石:治疗应用及其他。
PNAS Nexus. 2024 May 17;3(5):pgae198. doi: 10.1093/pnasnexus/pgae198. eCollection 2024 May.
2
Clay-Polymer Nanocomposites Mediated Inhibition of Protein Aggregation: Possible Role in the Prevention of Proteinopathies.粘土-聚合物纳米复合材料介导的蛋白质聚集抑制:在预防蛋白质病中的可能作用。
Protein Pept Lett. 2025;32(2):139-151. doi: 10.2174/0109298665274059231002071951.
3
Transcriptomics and Proteomics Approach for the Identification of Altered Blood microRNAs and Plasma Proteins in Parkinson's Disease.

本文引用的文献

1
Analysis of structural organization and interaction mechanisms of detonation nanodiamond particles in hydrosols.水溶胶中爆炸纳米金刚石颗粒的结构组织与相互作用机制分析。
Phys Chem Chem Phys. 2021 Jan 6;23(1):674-682. doi: 10.1039/d0cp05533f.
2
Coated nanodiamonds interact with tubulin beta-III negative cells of adult brain tissue.涂层纳米金刚石与成年脑组织中的微管蛋白β-III 阴性细胞相互作用。
Biointerphases. 2020 Dec 3;15(6):061009. doi: 10.1116/6.0000525.
3
The carbon ratio as a modulator of and toxicity of the chemically purified detonation-synthesized nanodiamond via the reactive oxygen species generation.
基于转录组学和蛋白质组学的帕金森病血液 microRNAs 和血浆蛋白质组改变的鉴定方法。
Cell Mol Neurobiol. 2023 Oct;43(7):3527-3553. doi: 10.1007/s10571-023-01362-4. Epub 2023 May 23.
4
Application of Nano-Crystalline Diamond in Tribology.纳米晶金刚石在摩擦学中的应用。
Materials (Basel). 2023 Mar 28;16(7):2710. doi: 10.3390/ma16072710.
碳比通过活性氧物种生成调节化学纯化爆轰合成纳米金刚石的 和 毒性。
Nanotoxicology. 2020 Nov;14(9):1213-1226. doi: 10.1080/17435390.2020.1813825. Epub 2020 Sep 14.
4
Controlled Doping of GeV and SnV Color Centers in Diamond Using Chemical Vapor Deposition.利用化学气相沉积法对金刚石中的GeV和SnV色心进行可控掺杂
ACS Appl Mater Interfaces. 2020 Jul 1;12(26):29700-29705. doi: 10.1021/acsami.0c07242. Epub 2020 Jun 16.
5
Carbon nanostructures as multi-functional drug delivery platforms.作为多功能药物递送平台的碳纳米结构。
J Mater Chem B. 2013 Jan 28;1(4):401-428. doi: 10.1039/c2tb00085g. Epub 2012 Nov 7.
6
Loading Amlodipine on Diamond Nanoparticles: A Novel Drug Delivery System.将氨氯地平负载于金刚石纳米颗粒上:一种新型药物递送系统。
Nanotechnol Sci Appl. 2019 Dec 31;12:47-53. doi: 10.2147/NSA.S232517. eCollection 2019.
7
Biological impact of nanodiamond particles - label free, high-resolution methods for nanotoxicity assessment.纳米金刚石颗粒的生物学影响 - 用于纳米毒性评估的无标记、高分辨率方法。
Nanotoxicology. 2019 Nov;13(9):1210-1226. doi: 10.1080/17435390.2019.1650970. Epub 2019 Sep 14.
8
Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma.树突状细胞介导的阿霉素-聚甘油-纳米金刚石复合材料的递送引发胶质母细胞瘤中增强的抗肿瘤免疫反应。
Biomaterials. 2018 Oct;181:35-52. doi: 10.1016/j.biomaterials.2018.07.035. Epub 2018 Jul 26.
9
Intracellular Trafficking of Fluorescent Nanodiamonds and Regulation of Their Cellular Toxicity.荧光纳米金刚石的细胞内运输及其细胞毒性的调控
ACS Omega. 2017 Jun 30;2(6):2689-2693. doi: 10.1021/acsomega.7b00339. Epub 2017 Jun 16.
10
Alzheimer's disease: clinical update on epidemiology, pathophysiology and diagnosis.阿尔茨海默病:流行病学、病理生理学及诊断的临床进展
Australas Psychiatry. 2018 Aug;26(4):347-357. doi: 10.1177/1039856218762308. Epub 2018 Apr 3.